Unlock instant, AI-driven research and patent intelligence for your innovation.

Strongylus duodenalis anticoagulant peptide, as well as preparation and use thereof

A technology of duodenum and anticoagulant peptides, which is applied in the fields of medicine and biology, and can solve problems such as prolonged prothrombin time and weak prothrombin time

Inactive Publication Date: 2012-09-05
GUANGDONG MEDICAL UNIV
View PDF13 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But so far, the anticoagulant peptides isolated from H. duodenale are limited to AduNAP7 and AduNAP4 (only partial sequences), and the two anticoagulant peptides are mainly characterized by prolonging the activated partial thromboplastin time (aPTT). ) activity, but relatively weak to prolonging the prothrombin time (PT) effect (the anticoagulant effect of AduNAP4 can be seen in the results to be published by the inventor), indicating that they mainly act on endogenous coagulation factors or \ coagulation factor

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Strongylus duodenalis anticoagulant peptide, as well as preparation and use thereof
  • Strongylus duodenalis anticoagulant peptide, as well as preparation and use thereof
  • Strongylus duodenalis anticoagulant peptide, as well as preparation and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0057] Isolation and Analysis of Coding Sequence of Anticoagulant Peptide AdAP1 from Ancylostoma duodenale

[0058] 1. Construction and sequencing screening of simple cDNA library of Ancylostoma duodenale

[0059] Fifteen adult worms of Ancylostoma duodenale obtained from humans were obtained, and total RNA was extracted with TRIzol Reagent (Invitrogen) according to the operating instructions. According to the operating instructions, 3'-Full RACE Core Set (Dalian Takara) was used to reverse transcribe the extracted total RNA of Ancylostoma duodenale to obtain the first-strand cDNA. Design the upstream primer NSL: GGTTTAATTACCCAAGTTTGAG according to the nematode spliced ​​leader sequence (spliced ​​leader) SL1, and use the anchor primer (SAP: CTGATCTAGAGGTACCGGATCC) sequence provided by the 3'-Full RACE Core Set kit as the downstream primer to amplify the first-strand cDNA; The amplified product was ligated into pUCm-T Vector, transformed into E.coli DH5α competent cells, and ...

Embodiment 2

[0064] Amplification of Anticoagulant Peptide AdAP1 from Ancylostoma duodenale by RT-PCR

[0065] Fifteen adult worms of Ancylostoma duodenale obtained from humans were obtained, and total RNA was extracted with TRIzol Reagent (Invitrogen) according to the operating instructions. The first-strand cDNA was obtained by reverse-transcribing the total RNA extracted from the adult worms of Ancylostoma duodenale using 3'-Full RACE Core Set (product of Takara, Dalian) according to the operating instructions. According to the amino acid sequence of the complete coding frame of AdAP1, that is, AdAP1f (SEQ ID NO.1), the predicted mature peptide sequence, that is, AdAP1m (SEQ ID NO.2), and the amino-terminal and carboxy-terminal of the predicted mature peptide are respectively missing 3 amino acids The sequence of AdAP1d (SEQ ID NO.3) is the nucleotide sequence shown in the design of primers, using Ancylostoma duodenale cDNA as a template for amplification.

[0066] The primers for ampl...

Embodiment 3

[0077] Recombinant Expression, Isolation and Purification of Anticoagulant Peptide AdAP1 from Ancylostoma duodenale

[0078] According to the coding sequence shown in sequence SEQ ID NO.1, SEQ ID NO.2, SEQ ID NO.3, i.e. SEQ ID NO.5, SEQ ID NO.6, SEQ ID NO.7, design and synthesize paired primers respectively, amplify Addition is the target fragment for further connection with the expression vector. Introduce the Kpn I enzyme cleavage site (GGTACC, see single-line underline) in the upstream primer, and a polynucleotide encoding the enterokinase cleavage site (see double-line underline. Enterokinase cleavage site amino acid sequence: DDDDK), downstream primers include Contains stop codon TGA and Xho I digestion (CTCGAG, see wavy underline).

[0079] (a) The sequences of primers dP2-1e and dP2-2e for amplifying the coding sequence of SEQ ID NO.1 (ie, SEQ ID NO.5) are as follows:

[0080] dP1-1e:

[0081] 5'-CA GGTACC ATGAAATTAATTTGTACCCAGGT-3' (containing Kpn I endonuclease...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an ancylostoma duodenale anticoagulant peptide as well as a coded sequence and a preparation method thereof. The obtained ancylostoma duodenale anticoagulant peptide has the anticoagulating activity, can remarkably prolong the human plasma prothrombin time (PT) as well as the activated partial thromboplastin time (aPTT), is more remarkable in prolonging the PT activity andcan obviously prevent the thrombus from being formed. The invention also relates to an application of the anticoagulant peptide on anticoagulative drugs, antithrombotic drugs or anticoagulative preparation.

Description

technical field [0001] The invention relates to the fields of medicine and biotechnology. Specifically, the present invention describes a new anticoagulant polypeptide-Ancylostoma duodenale anticoagulantpeptidel (AdAP1) gene and its encoded protein. The present invention also relates to the preparation and application of the anticoagulant peptide of hookworm duodenum and the nucleotide encoding the peptide. technical background [0002] Among the current human diseases, thromboembolic diseases have become the main factor that endangers human health. The total number of deaths caused by thromboembolism, such as myocardial infarction, cerebral infarction, and pulmonary infarction, ranks first among various causes. How to prevent and treat such diseases is the key Current hotspots in clinical and medical science research. Although heparin, oral coumarin, streptokinase and urokinase have been used for many years, the side effects of these drugs, such as bleeding and thrombocyt...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K14/44C12N15/30C12N15/63C12N15/70A61K39/002A61P7/02
Inventor 彭礼飞邓莉胡晶晶杨陈甘伟琼吴亚敏廖淑莉
Owner GUANGDONG MEDICAL UNIV